References
[1]. Bhatt, Deepak L et al. “Diagnosis and Treatment of Acute Coronary Syndromes: A Review.” JAMA vol. 327,7 (2022): 662-675
[2]. Samady Habib,Jaber Wissam. Harnessing Vascular Biology and Fluid Dynamics to Risk Stratify Patients With Acute Coronary Syndromes[J]. JACC: Cardiovascular Interventions,2022,15(20).
[3]. Kakizaki Shunsuke,Otake Hiromasa,Seike Fumiyasu,et al.Optical Coherence Tomography Fractional Flow Reserve and Cardiovascular Outcomes in Patients With Acute Coronary Syndrome[J]. JACC: Cardiovascular Interventions,2022,15(20)
[4]. Sabouret Pierre,Puymirat Etienne,Kownator Serge,ect. Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice.[J]. Panminerva medica,2022
[5]. Okada Kozo,Kikuchi Shinnosuke,Kuji Shotaro,et al. Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes[J]. Atherosclerosis,2022,360
[6]. Verdoia Monica,Nardin Matteo,Gioscia Rocco,et al.Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor.[J]. Minerva cardiology and angiology,2022
[7]. Masoodi Khabar Parisa,Ghydari Mohamad Esmail,Vazifeh Shiran Nader,et al. Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome.[J]. Laboratory medicine,2022
[8]. Träff Erik,Venetsanos Dimitrios,Alpkvist Karin,et al.Real-world data on potent P2Y12-inhibition in patients with suspected chronic coronary syndrome, referred for coronary angiography.[J]. Cardiology,2022
[9]. McLachlan Andrew,Kerr Andrew,Lee Mildred. A nurse-led and medically supported outpatient follow-up model following an acute coronary syndrome is as safe and effective as medical follow-up alone (ANZACS-QI 69.[J]. The New Zealand medical journal,2022,135(1563)
[10]. Wei Danting,Somaratne Jithendra B,Lee Mildred,et al. Revascularisation and outcomes after acute coronary syndromes in patients with prior coronary artery bypass grafting-ANZACS-QI 67.[J]. The New Zealand medical journal,2022,135(1563)
[11]. Sriranjan Rouchelle,Zhao Tian Xiao,Tarkin Jason,et al. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.[J]. BMJ open,2022,12(10)
[12]. Liu Chi,Liu Xiaoli,Ma Xiaoteng，et al. Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention[J]. Diabetology & Metabolic Syndrome,2022,14(1)
[13]. Núñez Julio,Lorenzo Miguel,Miñana Gema,et al.Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome.[J]. ESC heart failure,2022
[14]. Wouters Loes T C M,Zwart Dorien L M,Erkelens Daphne C A,et al. Development and validation of a prediction rule for patients suspected of acute coronary syndrome in primary care: a cross-sectional study.[J]. BMJ open,2022,12(10)
[15]. Pernaje Seetharam Smitha,Shankar Ms Vinutha,Udupa Kaviraja,et al. Prognostic value of heart rate variability in acute coronary syndrome.[J]. Journal of basic and clinical physiology and pharmacology,2022
[16]. Pârv AndreeaAmalia,Vajas Cristina,Anchidin Ovidiu,Puiu Andrei,et al. Unusual echocardiographic finding as cause of acute coronary syndrome with ST- segment elevation.[J]. Medical ultrasonography,2022
[17]. Cristo Ropero María José,Rivera Rabanal Francisco Javier,Seoane García Tania,et al. Utility of pulmonary echography with a handheld ultrasound device in patients with acute coronary syndrome.[J]. Internal and emergency medicine,2022.
[18]. ter Hoeve Nienke,Jorstad Harald T.,Sunamura Madoka,et al. Know Your Numbers: Patient and Physician Disparity in Cardiovascular Risk Perception After an Acute Coronary Syndrome[J]. Journal of Cardiopulmonary Rehabilitation and Prevention,2022
[19]. Syed Ajia,Hashmani Shahrukh,Darr Umer,et al. Polyvascular Disease in the Gulf Region: Concealed Marker of Poor Outcomes in Acute Coronary Syndrome[J]. Current Problems in Cardiology,2022,47(12)
[20]. de Carvalho Costa Ingrid Maria Novais Barros,Silva Danielle Góes da,Oliveira Joselina Luzia Meneses,Silva José Rodrigo Santos,et al. Adherence to secondary prevention measures after acute coronary syndrome in patients associated exclusively with the public and private healthcare systems in Brazil[J]. Preventive Medicine Reports,2022,29
[21]. Amadio G.,Shughart L,Watts P.,et al. Exploration of Uncertainty Scale Use in Patients With Potential Acute Coronary Syndrome[J]. Annals of Emergency Medicine,2022,80(4S)
[22]. Bhatt, Deepak L et al. “Diagnosis and Treatment of Acute Coronary Syndromes: A Review.” JAMA vol. 327,7 (2022): 662-675
[23]. Trent S.,Gravitz S.,Krantz M.,et al. Effect of High-sensitivity Troponin on Emergency Department Length of Stay for Patients Evaluated for Acute Coronary Syndrome[J]. Annals of Emergency Medicine,2022,80(4S)
Cite this article
Wu,K. (2023). Prevention and Treatment of Acute Coronary Artery Syndrome. Theoretical and Natural Science,4,684-691.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part II
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).
References
[1]. Bhatt, Deepak L et al. “Diagnosis and Treatment of Acute Coronary Syndromes: A Review.” JAMA vol. 327,7 (2022): 662-675
[2]. Samady Habib,Jaber Wissam. Harnessing Vascular Biology and Fluid Dynamics to Risk Stratify Patients With Acute Coronary Syndromes[J]. JACC: Cardiovascular Interventions,2022,15(20).
[3]. Kakizaki Shunsuke,Otake Hiromasa,Seike Fumiyasu,et al.Optical Coherence Tomography Fractional Flow Reserve and Cardiovascular Outcomes in Patients With Acute Coronary Syndrome[J]. JACC: Cardiovascular Interventions,2022,15(20)
[4]. Sabouret Pierre,Puymirat Etienne,Kownator Serge,ect. Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice.[J]. Panminerva medica,2022
[5]. Okada Kozo,Kikuchi Shinnosuke,Kuji Shotaro,et al. Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes[J]. Atherosclerosis,2022,360
[6]. Verdoia Monica,Nardin Matteo,Gioscia Rocco,et al.Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor.[J]. Minerva cardiology and angiology,2022
[7]. Masoodi Khabar Parisa,Ghydari Mohamad Esmail,Vazifeh Shiran Nader,et al. Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome.[J]. Laboratory medicine,2022
[8]. Träff Erik,Venetsanos Dimitrios,Alpkvist Karin,et al.Real-world data on potent P2Y12-inhibition in patients with suspected chronic coronary syndrome, referred for coronary angiography.[J]. Cardiology,2022
[9]. McLachlan Andrew,Kerr Andrew,Lee Mildred. A nurse-led and medically supported outpatient follow-up model following an acute coronary syndrome is as safe and effective as medical follow-up alone (ANZACS-QI 69.[J]. The New Zealand medical journal,2022,135(1563)
[10]. Wei Danting,Somaratne Jithendra B,Lee Mildred,et al. Revascularisation and outcomes after acute coronary syndromes in patients with prior coronary artery bypass grafting-ANZACS-QI 67.[J]. The New Zealand medical journal,2022,135(1563)
[11]. Sriranjan Rouchelle,Zhao Tian Xiao,Tarkin Jason,et al. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.[J]. BMJ open,2022,12(10)
[12]. Liu Chi,Liu Xiaoli,Ma Xiaoteng，et al. Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention[J]. Diabetology & Metabolic Syndrome,2022,14(1)
[13]. Núñez Julio,Lorenzo Miguel,Miñana Gema,et al.Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome.[J]. ESC heart failure,2022
[14]. Wouters Loes T C M,Zwart Dorien L M,Erkelens Daphne C A,et al. Development and validation of a prediction rule for patients suspected of acute coronary syndrome in primary care: a cross-sectional study.[J]. BMJ open,2022,12(10)
[15]. Pernaje Seetharam Smitha,Shankar Ms Vinutha,Udupa Kaviraja,et al. Prognostic value of heart rate variability in acute coronary syndrome.[J]. Journal of basic and clinical physiology and pharmacology,2022
[16]. Pârv AndreeaAmalia,Vajas Cristina,Anchidin Ovidiu,Puiu Andrei,et al. Unusual echocardiographic finding as cause of acute coronary syndrome with ST- segment elevation.[J]. Medical ultrasonography,2022
[17]. Cristo Ropero María José,Rivera Rabanal Francisco Javier,Seoane García Tania,et al. Utility of pulmonary echography with a handheld ultrasound device in patients with acute coronary syndrome.[J]. Internal and emergency medicine,2022.
[18]. ter Hoeve Nienke,Jorstad Harald T.,Sunamura Madoka,et al. Know Your Numbers: Patient and Physician Disparity in Cardiovascular Risk Perception After an Acute Coronary Syndrome[J]. Journal of Cardiopulmonary Rehabilitation and Prevention,2022
[19]. Syed Ajia,Hashmani Shahrukh,Darr Umer,et al. Polyvascular Disease in the Gulf Region: Concealed Marker of Poor Outcomes in Acute Coronary Syndrome[J]. Current Problems in Cardiology,2022,47(12)
[20]. de Carvalho Costa Ingrid Maria Novais Barros,Silva Danielle Góes da,Oliveira Joselina Luzia Meneses,Silva José Rodrigo Santos,et al. Adherence to secondary prevention measures after acute coronary syndrome in patients associated exclusively with the public and private healthcare systems in Brazil[J]. Preventive Medicine Reports,2022,29
[21]. Amadio G.,Shughart L,Watts P.,et al. Exploration of Uncertainty Scale Use in Patients With Potential Acute Coronary Syndrome[J]. Annals of Emergency Medicine,2022,80(4S)
[22]. Bhatt, Deepak L et al. “Diagnosis and Treatment of Acute Coronary Syndromes: A Review.” JAMA vol. 327,7 (2022): 662-675
[23]. Trent S.,Gravitz S.,Krantz M.,et al. Effect of High-sensitivity Troponin on Emergency Department Length of Stay for Patients Evaluated for Acute Coronary Syndrome[J]. Annals of Emergency Medicine,2022,80(4S)